Navigation Links
GenVec Reports Third Quarter 2009 Financial Results
Date:11/5/2009

Research (SBIR) grant from the NIH to support the development of novel cell lines capable of producing vaccine vectors based on different human serotype groups and encoding inhibitory antigens.
  • GenVec announced that the NIAID executed the third option period (year four) under a previously announced, five-year contract with GenVec for the production of HIV vaccines. GenVec will receive up to $2.3 million in fourth-year funding to support the generation of HIV vaccine candidates.
  • GenVec strengthened its cash position by raising $6.0 million from a single institutional investor. Proceeds of this transaction, net of offering costs, totaled $5.6 million.
  • GenVec was awarded a SBIR grant, valued at approximately $300,000, from the National Cancer Institute of the NIH to support the research of a new approach to treating metastatic cancer.

    • Conference Call Information

    GenVec will hold a conference call at 10:00 a.m. EST on Friday, November 6, 2009 to discuss the Company's third quarter results. To listen to the live conference call, please dial 888-679-8040 (U.S. or Canada) or 617-213-4851 (international) and use access code 35178683. Participants may pre-register for the call anytime at: https://www.theconferencingservice.com/prereg/key.process?key=PPCBK3H6R.

    Pre-registrants will be issued a PIN number to use when dialing into the live call, which will provide quick access to the conference. An audio replay of the conference call will be available starting at 1:00 p.m. on November 6, 2009 through November 12, 2009. To listen to the audio replay, dial 888-286-8010 (U.S. or Canada) or 617-801-6888 (international) and use access code 28987203.

    A live webcast of the conference call will be available on the Company's website and will be archived for 30 days. To access the webcast or th
    '/>"/>

    SOURCE GenVec, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    0

    GOOD

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
    2. GenVec Expands Contract Supporting Malaria Vaccine Program
    3. GenVec Reports Second Quarter 2009 Financial Results
    4. GenVec Receives an Approximately $2.5 Million Grant to Support Novel Cell Line Development
    5. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
    6. GenVec Announces Third Quarter 2009 Results Conference Call
    7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
    8. QMed, Inc. Reports July Medicare SNP Enrollments
    9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
    10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
    11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007

    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/24/2009)...Newswire/--Twomoreprestigiousuniversitieshavejoine...ndcareerssiteforlifescienceprofessionals. ,, No...obboard,joining28othermajorlifesciencetrainingInst...om ,isonlyforpost-graduatesinthelifesciences.While...net,BioCareerCenteristheonlyonethatserveslifescien...
    (Date:11/24/2009)...24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Nas...rstday"motionsbytheU.S.BankruptcyCourtfortheDistri...filedavoluntarypetitionfor,reliefunderChapter11oft...t. , TheordersissuedbytheBankruptcyCourtallow...Chapter11proceedings.Inparticular,the,companyrecei...
    (Date:11/24/2009)...recently approved the Promega PowerPlex 16 HS Syst...erating DNA records for the National DNA Index Sys...RWEB) -- The FBI recently approved the Promega Po... participating in, or generating DNA records for, ...ly contains more than seven million profiles and h...
    (Date:11/24/2009)...PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq: ...ExecutiveChairman,willpresentatthe21stAnnualPiperJ...ecember1,2009at10:00a.m.ET. ,, Toaccessthelivea...ittheInvestorRelationssectionofGenomicHealth,swebs...necttothewebsiteatleast15minutespriortothebeginnin...
    Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2
    ... by leading European authority on natural/ organi... 6 /PRNewswire-FirstCall/ - Botaneco Specialty Ing...s Genetics Inc. (SemBioSys), today,announced that ...M) G2, has,been authorized by ECOCERT(R) as an app...or ecological and organic cosmetics. ECOCERT(R) is...
    ... Glemser Technologies, a Bethlehem, PA based pharm...ounced SPL for DCM, a new out-of-the-box labeling ...ce Manager (DCM) application. SPL for DCM provide...and addresses the SPL Release 4 submission standar...ddition to Glemser,s family of pharmaceutical labe...
    ...nome contains many genes encoding proteins that ar...evolutionary relationships; however, protein-codin...me, and there are many other DNA sequences that ar...ces doing, and do we really need them at all? In ... ( www.genome.org ), researchers have delved into...
    Other Biology Technology:Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2 2Botaneco receives natural ingredient approval from ECOCERT(R) for Hydresia(TM) G2 3Glemser Announces New Labeling Solution: SPL for DCM Addresses New SPL Release 4 Requirements 2Use it or lose it? Researchers investigate the dispensability of our DNA 2
    (Date:11/24/2009)...understanding how sounds associated with Navy sona...if they hear it at all. , The same type of large... detect flaws in the space shuttle,s behemoth soli...inside the giant head of a whale. The scans are pr...hale,s hearing anatomy using a breakthrough method...
    (Date:11/24/2009)...teries from collapsing have been true life-savers....needed -- once the arteries are strengthened, they...oice but to leave them in place. , Prof. Meital ...iomedical Engineering has developed a new patent-p...y,re needed, then dissolves. , "Our new composit...
    (Date:11/24/2009)...dical Toxicology (ACMT) have signed an agreement t...f Medical Toxicology (JMT), the official journal ...iously published by the University of Pennsylvania...an international, peer-reviewed journal, is dedica...al toxicology. The quarterly journal focuses on t...
    Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2A coating for life 2Springer and the American College of Medical Toxicology to work together 2Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 1Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 2Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 3Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 4Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 5Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 6Amgen to Discuss Denosumab Data at Todays Advisory Committee for Reproductive Health Drugs 54404 7Spectral announces second quarter 2009 results 13544 1Spectral announces second quarter 2009 results 13544 2Spectral announces second quarter 2009 results 13544 3Spectral announces second quarter 2009 results 13544 4Spectral announces second quarter 2009 results 13544 5Spectral announces second quarter 2009 results 13544 6Spectral announces second quarter 2009 results 13544 7Spectral announces second quarter 2009 results 13544 8Bill 26 Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office 54399 1Bill 26 Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office 54399 2Bill 26 Melinda Gates Foundation Appoints Joe Cerrell to Lead New European Office 54399 3
    ...Pacific Ocean has increased since international an...d 70s, according to a new study funded primarily b...chers throughout the Pacific region. , However,...y those in the Western Pacific Ocean, have not rec...rs. , The new research reveals that the overall p...
    ...y commodities worldwide has heightened concerns ab...nflict in the Middle East, terrorism and resource ...y Rice University,s Baker Institute for Public Pol... risks driving the oil price premium may be less c...ecutive summary may be found at www.rice.edu/nati...
    ...r. Jon Miller of Stevens Institute of Technology a... Sea Grant Program will present the 6th annual Sta...J beaches, as we head into the peak Jersey Shore t...ioner Lisa Jackson, Secretary of Agriculture Charl... the New Jersey Marine Sciences Consortium and Nan...
    Other Biology News:New study finds most North Pacific humpback whale populations rebounding 2Baker Institute study, conference weigh risks for global energy markets 2
    Duck Anti-Cobra venom - Fab Fragment Polyclonal Antibody, Unconjugated from Abcam
    Rabbit Anti-Fas-ligand Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
    Anti-Laminin alpha 2 (Merosin M chain) Monoclonal Antibody, Unconjugated, Clone 5H2 from CHEMICON
    Goat Anti-Human Rabenosyn 5 Polyclonal Antibody, Unconjugated from Abcam
    Biology Products: